Original Research

Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)

Ulmeanu R, Bloju S, Vittos O

Journal of Asthma and Allergy 2022, 15:919-933

Published Date: 8 July 2022